Newsfeeds Archive - Spark Newswire

1 minute read

Nasdaq Grants Sesen Bio Exception From Listing Non-Compliance To Complete Proposed Merger With Carisma Therapeutics

February 28, 3:25 AM

On February 24, 2023, Sesen Bio, Inc. (the “Company”) received a determination from The Nasdaq Stock Market LLC (“Nasdaq”) Office of General Counsel that the Nasdaq Hearings Panel (the

SESN

7 minute read

M&A
News

Sesen Bio Files Definitive Proxy Statement And Mails Letter To Stockholders In Connection With Pending Merger With Carisma Therapeutics

By Benzinga Newsdesk

January 19, 5:29 PM

Schedules March 2, 2023, Special Meeting of Stockholders to Vote on Merger Launches www.SesenBioandCarisma.com, Providing Additional Information for Stockholders Sesen Bio, Inc. (NASDAQ:SESN) today announced that

SESN

3 minute read

Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%

By Lisa Levin

December 30, 3:37 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday.

CLMT

3 minute read

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

December 30, 1:28 PM

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.

ALLR

1 minute read

Why Sesen Bio Shares Are Skyrocketing Friday?

By Henry Khederian

December 30, 11:50 AM

Sesen Bio Inc (NASDAQ: SESN) shares are trading higher by 16.81% to $0.59 Friday morning after the company and Carisma Therapeutics announced an increased special dividend of $70 million, or $0.34 per share, in connection with the pending merger. What Else?

SESN

3 minute read

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket

By Lisa Levin

December 30, 7:26 AM

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.

ARBK

1 minute read

Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday

By Lisa Levin

December 30, 5:05 AM

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

DRMA

1 minute read

Watching Sesen Bio; Zacks Equity Research Upgrades Stock To Buy

By Benzinga Newsdesk

November 30, 12:47 PM

SESEN BIO, INC. (SESN) Upgraded to Buy: What Does It Mean for the Stock? - November 30, 2022 - Zacks.com

SESN

1 minute read

Earnings

Sesen Bio: Q3 Earnings Insights

By Benzinga Insights

November 7, 10:36 AM

Sesen Bio (NASDAQ:SESN) reported its Q3 earnings results on Monday, November 7, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Sesen Bio beat estimated earnings by 166.67%, reporting an EPS of $0.1 versus an estimate of $-0.15.

SESN

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

November 7, 8:37 AM

Gainers Cidara Therapeutics (NASDAQ:CDTX) shares rose 14.6% to $0.64 during Monday's pre-market session. The market value of their outstanding shares is at $44.9 million. The company's, Q3 earnings came out 2 days ago.

ATNX